This new article from Forbes explores transcranial magnetic stimulation (TMS) as a transformative depression treatment that uses magnetic pulses to stimulate brain regions associated with mood regulation. TMS, a non-invasive, FDA-cleared therapy, benefits patients resistant to traditional antidepressants, showing up to 83% response rates. It requires no sedation or downtime and is now widely covered by insurance. Unlike electroconvulsive therapy, TMS is outpatient and well-tolerated, offering hope for both adults and adolescents struggling with depression and related conditions.
Read the article here: Forbes
Comments